Related Experiment Video

Updated: Jul 4, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.2K

Comparison Pharmacokinetic Dosing Tools in Hemophilia A Children

Can Alp Genç1, Dilek Gürlek Gökçebay2, Vildan Koşan Çulha2

  • 1Department of Pediatrics, Ankara City Hospital, University of Health Sciences, Ankara, Turkey.

Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|February 5, 2024
PubMed

Insights

Choosing the right pharmacokinetic (PK) dosing tool is crucial for optimizing factor VIII (FVIII) prophylaxis in hemophilia A. Different tools can lead to varying FVIII dose recommendations, highlighting the need for individualized treatment plans.

Area of Science:

  • Hematology
  • Pharmacokinetics
  • Medical Informatics

Background:

  • Prophylaxis is the standard of care for hemophilia A, aiming to reduce bleeding events.
  • Pharmacokinetic (PK)-guided prophylaxis can decrease bleeding frequency and treatment costs.
  • Bayesian-based PK dosing tools have been developed to optimize prophylaxis regimens.

Purpose of the Study:

  • To compare the performance of two web-accessible PK dosing tools, WAPPS and myPKFiT.
  • To evaluate differences in recommended factor VIII (FVIII) doses and PK parameters between the tools.
  • To assess the impact of PK dosing tools on prophylaxis strategies for hemophilia A patients.

Main Methods:

  • A comparative study involving 42 severe hemophilia A, inhibitor-negative patients.
  • Collection of blood samples at multiple time points post-infusion for FVIII level measurement.
  • Utilized WAPPS and myPKFiT Bayesian PK dosing tools to estimate FVIII doses and PK parameters.

Main Results:

  • myPKFiT showed no significant difference in recommended FVIII dose compared to current prophylaxis for a 1% trough level, unlike WAPPS.
  • Significant differences were observed between WAPPS and myPKFiT in estimated dose, clearance, and time to reach a 1% trough level.
  • No significant variations in PK data were found based on the type of factor concentrate used (Advate® vs. non-Advate®).

Conclusions:

  • The selection of a PK dosing tool can influence the recommended FVIII dose for hemophilia A prophylaxis.
  • Individualizing target trough levels based on bleeding phenotype and patient activity is essential.
  • Further research may be needed to validate PK dosing tools and refine individualized prophylaxis strategies.

Keywords:
ClearanceDosing toolFactor VIIIHalf-lifeHemophilia APharmacokinetics

More Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.8K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

32.2K

Related Concept Videos

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
507
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
73
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding01:22

Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding

When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
176
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
253
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
375